Evidence map›Paper›PMID 33007920›Full record

ArticleToxins2020

Fumonisin B

Thilona Arumugam, Terisha Ghazi, Anil Chuturgoon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. mLife · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Fumonisin BToxins · 2021
    Article
  6. Review
  7. QuEChERS LC-MS/MS Screening Method for Mycotoxin Detection in Cereal Products and Spices.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Thilona ArumugamDiscipline of Medical Biochemistry and Chemical Pathology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, George Campbell Building, Howard College, University of KwaZulu-Natal, Durban 4041, South Africa.
Terisha GhaziDiscipline of Medical Biochemistry and Chemical Pathology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, George Campbell Building, Howard College, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0002-0179-213X
Anil ChuturgoonDiscipline of Medical Biochemistry and Chemical Pathology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, George Campbell Building, Howard College, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0003-4649-4133
University of KwaZulu-Natal · ZA

Funding

NRF (SOUTH AFRICA) 120820
6 · The paper itself

Abstract

Fumonisin B

Indexed as

DNA DamageCheckpoint Kinase 1Epigenesis, GeneticFumonisinsGene Expression Regulation, EnzymologicHepatocytesHep G2 CellsHumansJumonji Domain-Containing Histone DemethylasesNuclear ProteinsPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRepressor ProteinsSignal TransductionCheckpoint Kinase 1CHEK1 protein, humanfumonisin B1FumonisinsJumonji Domain-Containing Histone DemethylasesKDM5B protein, humanNuclear ProteinsPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanRepressor ProteinsCheckpoint Kinase 1DNA damageepigeneticsFumonisin B1H3K4me3PTEN

Identifiers

PMID33007920
PMCPMC7601513
OpenAlexW3091389143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.